Separate Impact of Obesity and Glucose Tolerance on the Incretin Effect in Normal Subjects and Type 2 Diabetic Patients

Muscelli, Elza, Mari, Andrea, Casolaro, Arturo, Camastra, Stefania, Seghieri, Giuseppe, Gastaldelli, Amalia, Holst, Jens J., Ferrannini, Ele·2008·Diabetes

DOI 10.2337/db07-1315

Cited by (409)

Items 201–300 of 409

Unraveling the impaired incretin effect in obesity and type 2 diabetes: Key role of hyperglycemia-induced unscheduled glycolysis and glycolytic overload
Naila Rabbani, Paul John Thornalley · 2024 · Diabetes Research and Clinical Practice
GLP-1 RAs as compared to prandial insulin after failure of basal insulin in type 2 diabetes: lessons from the 4B and Get-Goal DUO 2 trials
Francesca Porcellati, Paola Lucidi, Geremia B. Bolli, Carmine Giuseppe Fanelli · 2015 · Diabetes & Metabolism
Pharmacokinetic/Pharmacodynamic Modeling of GLP-1 in Healthy Rats
Yanguang Cao, Wei Gao, William J. Jusko · 2011 · Pharmaceutical Research
Effects of Aerobic Exercise with or without Metformin on Plasma Incretins in Type 2 Diabetes
Saeed Reza Toghi Eshghi, Gordon J. Bell, Normand G. Boulé · 2013 · Canadian Journal of Diabetes
New Approaches to Feline Diabetes Mellitus
Chen Gilor, Adam Joseph Rudinsky, M.J. Hall · 2016 · Journal of Feline Medicine and Surgery
Incretin and Glucagon Levels in Adult Offspring Exposed to Maternal Diabetes in Pregnancy
Louise Kelstrup, Tine Dalsgaard Clausen, Elisabeth Reinhardt Mathiesen, Torben F. Hansen, Jens Juul Holst, Peter Damm · 2015 · The Journal of Clinical Endocrinology & Metabolism
Regulation of Intermediary Metabolism During Fasting and Feeding
Ralph Anthony DeFronzo, Ele Ferrannini · 2015 · Elsevier eBooks
Circulating GLP-1 Levels as a Potential Indicator of Metabolic Syndrome Risk in Adult Women
Seon, Min Joo, Hwang, So Yoon, Son, Yujeong, Song, Juhyun, Kim, Oh Yoen · 2021 · Nutrients
A randomized triple-blind controlled clinical trial evaluation of sitagliptin in the treatment of patients with non-alcoholic fatty liver diseases without diabetes
Azam Doustmohammadian, Ahmad Nezhadisalami, Fahimeh Safarnezhad Tameshkel, Nima Motamed, Mansooreh Maadi, Mohammad Farahmand, Masoudreza Sohrabi, Cain C. T. Clark, Hossein Ajdarkosh, Amir Hossein Faraji et al. · 2022 · Frontiers in Medicine
Loss of the Incretin Effect in Type 2 Diabetes: A Systematic Review and Meta-analysis
Eleonora Grespan, Annamaria Guolo, Elza Muscelli, Ele Ferrannini, Andrea Mari · 2022 · The Journal of Clinical Endocrinology & Metabolism
Glucagon and other proglucagon-derived peptides in the pathogenesis of obesity
Jens Juul Holst · 2022 · Frontiers in Nutrition
Incretin action maintains insulin secretion, but not hepatic insulin action, in people with impaired fasting glucose
Leigh Perreault, Chiara Dalla Man, Devon M. Hunerdosse, Claudio Cobelli, Bryan C. Bergman · 2010 · Diabetes Research and Clinical Practice
Diabetes Remission Following Metabolic Surgery: Is GLP-1 the Culprit?
Josép Vidal, Amanda Jiménez · 2013 · Current Atherosclerosis Reports
Incretin secretion and serum DPP-IV activity in Korean patients with type 2 diabetes
Seung Jin Han, Hae Jin Kim, Sung‐E Choi, YUP Y. KANG, Kwan Woo Lee, Dae Jung Kim · 2010 · Diabetes Research and Clinical Practice
Impaired beta cell sensitivity to incretins in type 2 diabetes is insufficiently compensated by higher incretin response
Andrea Tura, Jonatan Ising Bagger, Ele Ferrannini, Jens Juul Holst, Filip Krag Knop, Tina Vilsbøll, Andrea Mari · 2017 · Nutrition Metabolism and Cardiovascular Diseases
Sleep apnea in men is associated with altered lipid metabolism, glucose tolerance, insulin sensitivity, and body fat percentage
Prasad G. Kamble, Jenny Theorell‐Haglöw, Urban Wiklund, Karl A. Franklin, Ulf Hammar, Eva Lindberg, Jan W. Eriksson · 2020 · Endocrine
Current Therapies That Modify Glucagon Secretion: What Is the Therapeutic Effect of Such Modifications?
Magnus F.G. Grøndahl, Damien J. Keating, Tina Vilsbøll, Filip Krag Knop · 2017 · Current Diabetes Reports
Obesity and Exercise: New Insights and Perspectives
James, Natasha Maria, Stanford, Kristin I · 2025 · Endocrine Reviews
Physiology of the Incretin Hormones, GIP and GLP ‐1—Regulation of Release and Posttranslational Modifications
Jens Juul Holst, Nicolai J Wewer Albrechtsen, METTE MARIE ROSENKILDE, Carolyn Fiona Deacon · 2019 · Comprehensive physiology
Intestinal Epithelial NAD+ Biosynthesis Regulates GLP-1 Production and Postprandial Glucose Metabolism in Mice
Taichi Nagahisa, Shintaro Yamaguchi, Shotaro Kosugi, Koichiro Homma, Kazutoshi Miyashita, Junichiro Irie, Jun Yoshino, Hiroshi Itoh · 2022 · Endocrinology
Nutrient Combinations Sensed by L-Cell Receptors Potentiate GLP-1 Secretion
Nalini Sodum, Orvokki Mattila, Ravikant Sharma, Remi Kamakura, Vesa‐Pekka Lehto, Jarosław Walkowiak, Karl‐Heinz Herzig, Ghulam Shere Raza · 2024 · International Journal of Molecular Sciences
Effect of GLP-1 receptor agonists on weight and cardiovascular outcomes: A review
Fatima Ali Raza, Rafiya Altaf, Talha Bashir, Fatima Asghar, Rabiya Altaf, Sohaib Tousif, Aman Goyal, Aisha Mohammed, Mahnoor Faisal Mohammad, Mahfuza Anan et al. · 2024 · Medicine
Effects of acute NEFA manipulation on incretin-induced insulin secretion in participants with and without type 2 diabetes
Brenno Astiarraga, Valéria Bahdur Chueire, Aglécio Luiz de Souza, Ricardo Pereira Moreira, Sarah Monte Alegre, Andrea Natali, Andrea Tura, Andrea Mari, Ele Ferrannini, Elza Muscelli · 2018 · Diabetologia
Energy intake, gastrointestinal transit, and gut hormone release in response to oral triglycerides and fatty acids in men with and without severe obesity
Carsten Dirksen, Jesper Graff, Stefan Fuglsang, Jens Frederik Rehfeld, Jens Juul Holst, Jan L. Madsen · 2018 · American Journal of Physiology-Gastrointestinal and Liver Physiology
Molecular mechanisms of lipoapoptosis and metformin protection in GLP-1 secreting cells
Camilla Krizhanovskii, Jens Juul Holst, Qimin Zhang, Åke Sjöholm · 2012 · Biochemical and Biophysical Research Communications
Incretin Hormones: Pathophysiological Risk Factors and Potential Targets for Type 2 Diabetes
Jared Rosenberg, Jordan Jacob, Priya Desai, Jeremy Park, Lorin Donovan, Joon Young Kim · 2021 · Journal of Obesity & Metabolic Syndrome
Glucagon-like peptide-1 secretion in people with versus without type 2 diabetes: a systematic review and meta-analysis of cross-sectional studies
Jonathan D. Watkins, S. Carter, Greg Atkinson, Françoise Koumanov, James A. Betts, Jens Juul Holst, Javier Thomas Gonzalez · 2022 · Metabolism
Incretin responses to oral glucose and mixed meal tests and changes in fasting glucose levels during 7 years of follow-up: The Hoorn Meal Study
Anitra D.M. Koopman, Femke Rutters, Simone P. Rauh, Giel Nijpels, Jens Juul Holst, Joline W. J. Beulens, Marjan Alssema, J. M. Dekker · 2018 · PLoS ONE
Insulin combined with C hinese medicine improves glycemic outcome through multiple pathways in patients with type 2 diabetes mellitus
Xinxia Zhang, Ya Liu, Daqian Xiong, Chunguang Xie · 2015 · Journal of Diabetes Investigation
Peripheral Signals Mediate the Beneficial Effects of Gastric Surgery in Obesity
Silvia Barja-Fernández, Cintia Folgueira, Cecilia Castelao, Rosaura Leis, Felipe F. Casanueva, Luisa Maria Seoane · 2015 · Gastroenterology Research and Practice
Efficacy and Safety of Sitagliptin in Japanese Patients With Type 2 Diabetes
Hirotoshi Ohmura, Tomoya Mita, Yoshinobu Taneda, Masahiro Sugawara, Hideaki Funayama, Joe Matsuoka, Hirotaka Watada, Hiroyuki Daida · 2015 · Journal of Clinical Medicine Research
GLP-1 response to sequential mixed meals: influence of insulin resistance
Eleni Rebelos, Brenno Astiarraga, Roberto Bizzotto, Andrea Mari, Maria Laura Manca, Alex Gonzalez, Armando J. Mendez, Claudia A. Martinez, Barry E. Hurwitz, Ele Ferrannini · 2017 · Clinical Science
Role of Surgery in Management of Type 2 Diabetes Mellitus
Daniel M. Herron, Winnie W.Y. Tong · 2009 · Mount Sinai Journal of Medicine A Journal of Translational and Personalized Medicine
Endurance Training Improves GLP-1 Sensitivity and Glucose Tolerance in Overweight Women
Åkerström, Thorbjörn, Stolpe, Malene N, Widmer, Renate, Dejgaard, Thomas F, Højberg, Jens M, Møller, Kirsten, Hansen, Jakob S, Trinh, Beckey, Holst, Jens J, Thomsen, Carsten et al. · 2022 · Journal of the Endocrine Society
RBx-0597, a potent, selective and slow-binding inhibitor of dipeptidyl peptidase-IV for the treatment of type 2 diabetes
Shuchita Singh, Sachin Sethi, Vivek Khanna, Biju Benjamin, Rajiv Kant, Jitendra A. Sattigeri, Vinay S. Bansal, Pradip Kumar Bhatnagar, Joseph A. Davis · 2010 · European Journal of Pharmacology
GLP-1RAs attenuated obesity and reversed leptin resistance partly via activating the microbiome-derived inosine/A2A pathway
Chunyan Dong, Bailing Zhou, Binyan Zhao, Ke Lin, Yaomei Tian, Rui Zhang, Daoyuan Xie, Siwen Wu, Li Yang · 2024 · Acta Pharmaceutica Sinica B
Improved Glycemic Control Enhances the Incretin Effect in Patients With Type 2 Diabetes
Zhibo An, Ronald L. Prigeon, David A. D’Alessio · 2013 · The Journal of Clinical Endocrinology & Metabolism
Clinical Characteristics of the Responders to Dipeptidyl Peptidase-4 Inhibitors in Korean Subjects with Type 2 Diabetes
Tae Jung Oh, Hye Seung Jung, Jae Hyun Bae, Yeong Gi Kim, Kyeong Seon Park, Young Min Cho, Kyong Soo Park, Seong Yeon Kim · 2013 · Journal of Korean Medical Science
Appetite-Regulating Hormones Are Reduced After Oral Sucrose vs Glucose: Influence of Obesity, Insulin Resistance, and Sex
Alexandra Grace Yunker, SHAN H. LUO, Sabrina Jones, Hilary M. Dorton, Jasmin M. Alves, BRENDAN C. ANGELO, ALEXIS W. DEFENDIS, Trevor A. Pickering, John R. Monterosso, Kathleen A. Page · 2020 · The Journal of Clinical Endocrinology & Metabolism
Long-term efficacy and safety of sitagliptin in the treatment of Japanese Type 2 diabetes (ASSET-K1) to a target of HbA1c <7%.
Hajime Maeda, Akira Kubota, Akira Kanamori, Yasushi Tanaka, Yasuo Terauchi, Ikuro Matsuba · 2013 · PubMed
Effect of Short-Term Increase in Meal Frequency on Glucose Metabolism in Individuals with Normal Glucose Tolerance or Impaired Fasting Glucose: A Randomized Crossover Clinical Trial
Masanobu Hibi, Sayaka Hari, Tohru F. Yamaguchi, Yuki Mitsui, Sumio Kondo, Mitsuhiro Katashima · 2019 · Nutrients
Role of GLP-1 induced glucagon suppression in type 2 diabetes mellitus.
Kristine Juul Hare · 2010 · PubMed
Postprandial incretin and islet hormone responses and dipeptidyl-peptidase 4 enzymatic activity in patients with maturity onset diabetes of the young
Signe Harring Østoft, Jonatan Ising Bagger, Torben F. Hansen, Bolette Hartmann, Oluf Borbye Pedersen, Jens Juul Holst, Filip Krag Knop, Tina Vilsbøll · 2015 · European Journal of Endocrinology
Pathogenesis of Type 2 Diabetes Mellitus
Ralph Anthony DeFronzo · 2018 · Endocrinology
Pharmacologic inhibition of somatostatin receptor 2 to restore glucagon counterregulation in diabetes
Hoffman, Emily G., D’Souza, Ninoschka C., Liggins, Richard T., Riddell, Michael C. · 2024 · Frontiers in Pharmacology
Greater glucagon-like peptide-1 responses to oral glucose are associated with lower central and peripheral blood pressures
Julie Rehné Lundgren, Kristine Færch, Daniel R. Witte, Anna Elisabet Jonsson, Oluf Borbye Pedersen, Torben F. Hansen, Torsten Lauritzen, Jens Juul Holst, Dorte Vistisen, Marit E. Jørgensen et al. · 2019 · Cardiovascular Diabetology
Metabolic consequences of discretionary fortified beverage consumption containing excessive vitamin B levels in adolescents
Shyamchand Mayengbam, Heidi Virtanen, Dustin S. Hittel, Charlene D Elliott, Raylene A. Reimer, Hans J. Vogel, Jane Shearer · 2019 · PLoS ONE
What is type 2 diabetes?
Meera Shah, Adrian V Vella · 2014 · Medicine
Obesity as a Disease
Michael A. Via, Jeffrey Ian Mechanick · 2014 · Current Obesity Reports
Elevated circulating fasting glucagon-like peptide-1 in surgical patients with aortic valve disease and diabetes
Camilla Krizhanovskii, Stelia Ntika, Christian Olsson, Per Olof Eriksson, Anders Franco‐Cereceda · 2017 · Diabetology & Metabolic Syndrome
Small intestinal physiology relevant to bariatric and metabolic endoscopic therapies: Incretins, bile acid signaling, and gut microbiome
Nienke van Olst, Suzanne Meiring, Maurits de Brauw, Jacques J.G.H.M. Bergman, Max Nieuwdorp, Donald Leonard van der Peet, Victor E. A. Gerdes · 2020 · Techniques and Innovations in Gastrointestinal Endoscopy
14-3-3-zeta mediates GLP-1 receptor agonist action to alter α cell proglucagon processing
Marlena M. Holter, Daryl J. Phuong, Isaac S. Lee, Mridusmita Saikia, Lisa Weikert, Samantha Fountain, Elizabeth T. Anderson, Qin Fu, Sheng Zhang, Kyle W. Sloop et al. · 2022 · Science Advances
Early postprandial glucagon surge affects postprandial glucose levels in obese and non-obese patients with type 2 diabetes
Junji Kozawa, Kohei Okita, Hiromi Iwahashi, Kazuya Yamagata, Akihisa Imagawa, Iichiro Shimomura · 2013 · Endocrine Journal
Adaptation of β-Cell and Endothelial Function to Carbohydrate Loading: Influence of Insulin Resistance
Barry E. Hurwitz, Neil Schneiderman, Jennifer B. Marks, Armando J. Mendez, Alex Gonzalez, Maria Magdalena Llabre, Steven R. Smith, Roberto Bizzotto, Eleonora Santini, Maria Laura Manca et al. · 2015 · Diabetes
Inadequate Glucagon Suppression During OGTT in Prediabetes: A Systematic Review and Meta-analysis
Lina Chang, Ying Liu, Yian Gu, Siyu Yan, Li Ding, Ming Rong Liu, Qing He · 2024 · The Journal of Clinical Endocrinology & Metabolism
A famsin-glucagon axis mediates glucose homeostasis
Aijun Long, Yazhuo Wang, Yihua Guo, Jie Hong, Guang Ning, Zhuoxian Meng, Yiguo Wang, Yiguo Wang · 2024 · Cell Metabolism
Use of Concomitant Glucose-Lowering Therapies and Associated Treatment Results Observed in Clinical Trials of Twice-Daily Exenatide
Richard Pencek, Steven C. Brunell, Yan Li, Byron J. Hoogwerf, James K. Malone · 2012 · Endocrine Practice
Glucagon-like peptide 1 and dysglycemia: Conflict in incretin science
Awadhesh Kumar Singh · 2014 · Indian Journal of Endocrinology and Metabolism
Genetic, dietary, and non-dietary risk factors of obesity among preparatory-year female students at Taibah University, Saudi Arabia
Dalia E. El Nashar, Kholoud M. Alananbeh, Noora Al Hassan · 2016 · Journal of Taibah University for Science
The Effect of Short-term Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) Diet on Hunger Hormones, Anthropometric Parameters, and Brain Structures in Middle-aged Overweight and Obese Women: A Randomized Controlled Trial.
Golnaz Arjmand, Mojtaba Abbaszadeh, Majid Fardaei, Mohammad Hassan Eftekhari · 2022 · PubMed Central
Advances in obesity pharmacotherapy; learning from metabolic surgery and beyond
Dimitrios Tsilingiris, Alexander D. Kokkinos · 2023 · Metabolism
The amino acid response to a mixed meal in patients with type 2 diabetes: effect of sitagliptin treatment
Elza Muscelli, Silvia Frascerra, Arturo Casolaro, Simona Baldi, Andrea Mari, Walt Gall, J. Cobb, Ele Ferrannini · 2014 · Diabetes Obesity and Metabolism
Glucose dependent insulinotropic polypeptide and dipeptidyl peptidase inhibitors: Their roles in management of type 2 diabetes mellitus
A. Gupta, Hayder A. Al-Aubaidy, Bassim I Mohammed · 2016 · Diabetes & Metabolic Syndrome Clinical Research & Reviews
The Glucose-lowering Efficacy of Sitagliptin in Obese Japanese Patients with Type 2 Diabetes
Ryo Kodera, Kenichi Shikata, Akihiko Nakamura, Satoru Okazaki, Ryo Nagase, Tatsuaki Nakatou, Shigeru Haisa, Kazuyuki Hida, Katsuhiro Miyashita, Hirofumi Makino · 2017 · Internal Medicine
Role of fasting duration and weekday in incretin and glucose regulation
Kim Katrine Bjerring Clemmensen, Jonas Salling Quist, Dorte Vistisen, Daniel R. Witte, Anna Elisabet Jonsson, Oluf Borbye Pedersen, Torben F. Hansen, Jens Juul Holst, Torsten Lauritzen, Marit E. Jørgensen et al. · 2020 · Endocrine Connections
Diabète et corticoïdes : nouveautés et aspects pratiques
Marie Bastin, Fabrizio Andréelli · 2020 · La Revue de Médecine Interne
Cerebral effects of glucagon‐like peptide‐1 receptor blockade before and after Roux‐en‐Y gastric bypass surgery in obese women: A proof‐of‐concept resting‐state functional MRI study
Eelco van Duinkerken, Gabriel Bernardes, Liselotte van Bloemendaal, Dick J. Veltman, Frederik Barkhof, Daniel C. Mograbi, Victor E. A. Gerdes, Carolyn Fiona Deacon, Jens Juul Holst, Madeleine L. Drent et al. · 2020 · Diabetes Obesity and Metabolism
Pathogenesis of Type 2 Diabetes Mellitus
Ralph Anthony DeFronzo · 2018 · Endocrinology
Berberine activates the β-catenin/TCF4 signaling pathway by down-regulating miR-106b to promote GLP-1 production by intestinal L cells
Jiao Wang, Li-Rui Wei, Yanling Liu, Chengzhi Ding, Feng Guo, Jiao Wang, Qian Qin, Fengjiao Huang, Ying Xin, Shengnan Ma et al. · 2021 · European Journal of Pharmacology
Effects of small intestinal glucose on glycaemia, insulinaemia and incretin hormone release are load-dependent in obese subjects
L. Trahair, C. Marathe, S. Standfield, C. Rayner, C. Feinle-Bisset, M. Horowitz, K. Jones · 2017 · International Journal of Obesity
Glucose- and Bile Acid-Stimulated Secretion of Gut Hormones in the Isolated Perfused Intestine Is Not Impaired in Diet-Induced Obese Mice
Jenna Elizabeth Hunt, Jens Juul Holst, Sara Lind Jepsen · 2022 · Frontiers in Endocrinology
Lipotoxicity impairs incretin signalling
Vincent Poitout · 2012 · Diabetologia
The relationship between glucose and the liver-alpha cell axis – A systematic review
Thomas Pixner, Nathalie Stummer, Anna-Maria Schneider, Andreas Lukas, Karin Gramlinger, Valérie Julian, David Thivel, Katharina Mörwald, Harald Mangge, Christopher Dalus et al. · 2023 · Frontiers in Endocrinology
Inhibition of dipeptidyl peptidase-4: The mechanisms of action and clinical use of vildagliptin for the management of type 2 diabetes
Adrian V Vella, Galina Smushkin · 2009 · Diabetes Metabolic Syndrome and Obesity
Oleate increase neutral lipid accumulation, cellular respiration and rescues palmitate-exposed GLP-1 secreting cells by reducing ceramide-induced ROS
Stelia Ntika, Ketan Thombare, Masood Aryapoor, Hjalti Kristinsson, Peter Bergsten, Camilla Krizhanovskii · 2018 · Biochimie
Genome-Wide Association Analysis of Pancreatic Beta-Cell Glucose Sensitivity
Harshal Deshmukh, Anne Lundager Madsen, Ana Viñuela, Christian Theil Have, Niels Grarup, Andrea Tura, Anubha Mahajan, Alison J. Heggie, Robert Wilhelm Koivula, Federico De Masi et al. · 2020 · The Journal of Clinical Endocrinology & Metabolism
An impaired glucagon-like peptide-1 response is associated with prediabetes in polycystic ovary syndrome with obesity
Simona Ferjan, Mojca Jensterle, Tjaša Oblak, Irena Prodan Žitnik, Janja Marc, Katja Goričar, Vita Dolžan, Andrej Janež · 2019 · Journal of International Medical Research
Mineralocorticoid Receptor May Regulate Glucose Homeostasis through the Induction of Interleukin-6 and Glucagon-Like peptide-1 in Pancreatic Islets
Rieko Goto, Tatsuya Kondo, Kaoru Ono, Sayaka Kitano, Nobukazu Miyakawa, Takuro Watanabe, Masaji Sakaguchi, Miki Sato, Motoyuki Igata, Junji Kawashima et al. · 2019 · Journal of Clinical Medicine
Glucokinase and glucokinase activator
Changhong Li, Yi Zhang, Li Chen, Xiaoying Li · 2023 · Life Metabolism
Observation of incretin effects during enteral feed transitions of critically ill patients
Ummu Kulthum Jamaludin, Paul D. Docherty, J. Geoffrey Chase, Aaron Le Compte, Geoffrey M. Shaw, Thomas Desaive, Jean‐Charles Preiser · 2012 · e-SPEN Journal
Insulin Resistance and Hypertension
Sudha S. Shankar, Helmut O. Steinberg · 2012 · Humana Press eBooks
Antiobesity medications in adult and pediatric obesity and metabolic dysfunction–associated steatotic liver disease
Natalie S. Rodriguez, Phillipp Hartmann · 2025 · Pharmacological Reviews
Modulation of gut microbiota by crude gac aril polysaccharides ameliorates diet-induced obesity and metabolic disorders
Tai-Jung Lu, Wei-Chung Chiou, Hsiu‐Chen Huang, Heng‐Chih Pan, Chiao-Yin Sun, Tzong‐Der Way, Cheng Huang · 2024 · International Journal of Biological Macromolecules
Glucose-dependent insulinotropic polypeptide - a new link in the development of obesity
Ekaterina Alekseevna Shestakova, А. В. Ильин, Marina Vladimirovna Shestakova, Ivan Ivanovich Dedov · 2015 · Obesity and metabolism
Methods to Assess In Vivo Insulin Sensitivity and Insulin Secretion
Riccardo C. Bonadonna, Linda Boselli, Alessandra Dei, Maddalena Trombetta · 2018 · Endocrinology
Regulation of Intermediatory Metabolism During Fasting and Feeding
Ralph A. DeFronzo, Ele Ferrannini · 2010 · Elsevier eBooks
Adipositas und Diabetes
Jens Aberle, Anne Lautenbach, Svenja Meyhöfer, Sebastian M. Meyhöfer, Lars Selig, Matthias Blüher, Markus Menzen · 2021 · Diabetologie und Stoffwechsel
Evidence of a Gastro-Duodenal Effect on Adipose Tissue and Brain Metabolism, Potentially Mediated by Gut–Liver Inflammation: A Study with Positron Emission Tomography and Oral 18FDG in Mice
Maria Angela Guzzardi, Federica La Rosa, Daniela Campani, Andrea Cacciato Insilla, Monica Nannipieri, Maurizia Rossana Brunetto, Ferruccio Bonino, Patricia Iozzo · 2022 · International Journal of Molecular Sciences
Circulating glucagon-like peptide-1 level in patients with liver cirrhosis
Masoud Nouri‐Vaskeh, Neda Khalili, Amirreza Khalaji, Pouya Behnam, Leila Alizadeh, Sara Ebrahimi, Neda Gilani, Mehdi Mohammadi, Seyed Alisalar Madinehzadeh, Mohammad Zarei · 2020 · Archives of Physiology and Biochemistry
Assessment of the incretin effect in healthy subjects: concordance between clamp and OGTT methods
Aulinger, Benedikt A., D’Alessio, David A. · 2023 · American Journal of Physiology-Endocrinology and Metabolism
Lifestyle change reduces cardiometabolic risk factors and glucagon‐like peptide‐1 levels in obese first‐degree relatives of people with diabetes
Antia Bowes, Joe Begley, David E. Kerr · 2017 · Journal of Human Nutrition and Dietetics
La cirugía bariátrica como tratamiento de la diabetes tipo 2
David Benaiges, Albert Goday, Juan Pedro‐Botet · 2011 · Medicina Clínica
β‐Cell mass and function in human type 2 diabetes
Piero Marchetti, Ele Ferrannini · 2015 · Wiley eBooks
No detectable effect of a type 2 diabetes-associated TCF7L2 genotype on the incretin effect
David S. Mathiesen, Jonatan Ising Bagger, Katrine Bagge Hansen, Anders Ellekaer Junker, Astrid Plamboeck, Signe Harring Østoft, Thomas Idorn, Mads Hornum, Jens Juul Holst, Anna Elisabet Jonsson et al. · 2020 · Endocrine Connections
Obesity-related vascular dysfunction persists after weight loss and is associated with decreased vascular glucagon-like peptide receptor in female rats
Risa Kiernan, Dhandevi Persand, Nicole Maddie, Weikang Cai, Maria Alícia Carrillo-Sepúlveda · 2022 · American Journal of Physiology-Heart and Circulatory Physiology
Incretin Effect in Women with Former Gestational Diabetes within a Short Period after Delivery
Giovanni Pacini, Andrea Tura, Yvonne Winhofer, Alexandra Kautzky‐Willer · 2012 · International Journal of Endocrinology
Effects of Exenatide in a Morbidly Obese Patient with Type 2 Diabetes
Miyako Kishimoto, Mitsuhiko Noda · 2014 · Diabetes Therapy
Effect of Dietary Macronutrients on Postprandial Glucagon and Insulin Release in Obese and Normal-Weight Women
Tomasz Wikarek, Piotr Kocełak, Aleksander Jerzy Owczarek, Jerzy Tadeusz Chudek, Magdalena Olszanecka‐Glinianowicz · 2020 · International Journal of Endocrinology
Weight loss by calorie restriction does not alter appetite‐regulating gut hormone responses from perfused rat small intestine
Marina Kjærgaard Gerstenberg, Daniel B. Andersen, Lola Torz, Carlos M. Castorena, Angie L. Bookout, Bolette Hartmann, Jens Frederik Rehfeld, Natalia Petersen, Jens Juul Holst, Rune E. Kuhre · 2023 · Acta Physiologica
The Contribution of Enteroinsular Hormones to the Pathogenesis of Type 2 Diabetes Mellitus
Dima L. Diab, David A. D’Alessio · 2010 · Current Diabetes Reports